NASDAQ
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects....
HOLX's Diagnostics gains accelerate as U.S. molecular testing drives growth and new Panther Fusion and Genius platform approvals widen its runway....
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
First Trust Advisors LP cut its holdings in shares of Hologic, Inc. (NASDAQ: HOLX) by 83.4% during the undefined quarter, according to the company in its most recent disclosure with the Securities and...
Blue Door Asset Management LLC acquired a new position in shares of Hologic, Inc. (NASDAQ: HOLX) during the second quarter, according to the company in its most recent Form 13F filing with the Securit...
Hologic shares rise 16% in six months, with divisional strength clinical data and a go-private deal shaping the short-term outlook....
Edgestream Partners L.P. lifted its holdings in shares of Hologic, Inc. (NASDAQ: HOLX) by 75.5% during the undefined quarter, according to the company in its most recent 13F filing with the Securities...
HOLX's BCI test gains traction as new SABCS studies are set to highlight its growing role in guiding extended endocrine therapy decisions....
Hologic (HOLX) reported earnings 30 days ago. What's next for the stock?...
Arrowstreet Capital Limited Partnership lifted its holdings in shares of Hologic, Inc. (NASDAQ: HOLX) by 28.1% during the second quarter, according to the company in its most recent Form 13F filing wi...
No price data available for this timeframe.